학술논문
Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice.
Document Type
Article
Source
Subject
*ALCOHOLISM
*CLINICAL trials
*DRUG design
*HEALTH promotion
*INTERPROFESSIONAL relations
*MARKETING
*HEALTH policy
*MEDICAL prescriptions
*PHARMACEUTICAL industry
*DRUG development
*ALCOHOL-induced disorders
*INDIVIDUALIZED medicine
*DISEASE complications
*
*
*
*
*
*
*
*
*
*
*
*
Language
Abstract
The article offers information on priority areas for improving medications development for alcohol use disorder and promoting. It mentions about the drug development process more efficient in terms of speed, cost, and predictability and also focuses on the U.S. Food and Drug Administration's (FDA's) approval of disulfiram.